Fractional Inhibitory Concentration Index Calculator
Use this calculator to compute FIC for each agent and the combined FICI value from checkerboard MIC data.
Input MIC Values
Results
How to Calculate Fractional Inhibitory Concentration Index: Expert Guide for Clinical and Research Use
The fractional inhibitory concentration index, usually written as FICI, is a practical way to quantify how two or more antimicrobial agents behave when used together against a microorganism. In routine microbiology and antimicrobial research, FICI is commonly derived from checkerboard microdilution experiments, where each drug is tested across concentration gradients alone and in combination. The result can help categorize an interaction as synergistic, additive, indifferent, or antagonistic.
If you are learning how to calculate fractional inhibitory concentration index correctly, the most important idea is that each drug gets its own fractional inhibitory concentration (FIC) value first. You then sum those FIC values to obtain the final index. This guide explains the formula, interpretation caveats, data quality controls, and the practical steps that make your result more reproducible.
Core Formula
For a two-drug combination (A + B):
- FIC A = MIC of Drug A in combination / MIC of Drug A alone
- FIC B = MIC of Drug B in combination / MIC of Drug B alone
- FICI = FIC A + FIC B
For three drugs, you extend the same logic: FICI = FIC A + FIC B + FIC C. The calculator above supports both two-agent and optional three-agent computation.
Step-by-Step Calculation Example
- Measure MIC of Drug A alone: assume 8 mg/L.
- Measure MIC of Drug A in presence of Drug B: assume 2 mg/L.
- Compute FIC A = 2 / 8 = 0.25.
- Measure MIC of Drug B alone: assume 4 mg/L.
- Measure MIC of Drug B in presence of Drug A: assume 1 mg/L.
- Compute FIC B = 1 / 4 = 0.25.
- Compute FICI = 0.25 + 0.25 = 0.50.
- Interpretation under common checkerboard cutoffs: FICI 0.50 indicates synergy.
Interpretation Thresholds and Why They Differ
A major source of confusion is that not every paper uses identical FICI breakpoints. The most widely used framework in checkerboard studies is:
- Synergy: FICI ≤ 0.5
- Additive or partial synergy: FICI > 0.5 to 1.0
- Indifference: FICI > 1.0 to 4.0
- Antagonism: FICI > 4.0
Some groups apply stricter antagonism thresholds, such as > 2.0, especially when harmonizing with internal protocols. What matters most is transparency: always report the specific breakpoint system used in your methods.
| Framework | Synergy | Additive | Indifferent | Antagonism |
|---|---|---|---|---|
| Common checkerboard convention | ≤ 0.5 | > 0.5 to 1.0 | > 1.0 to 4.0 | > 4.0 |
| Conservative internal model (some labs) | ≤ 0.5 | > 0.5 to 1.0 | > 1.0 to 2.0 | > 2.0 |
Published Variability in Synergy Rates
One practical reality is that synergy rates differ by organism, resistance mechanism, method, endpoint definition, and even medium. The table below summarizes representative published ranges from peer-reviewed in vitro reports. These values are included to show that FICI outcomes are context-dependent rather than universal constants.
| Organism and combination | Typical sample sizes | Reported synergy rate (checkerboard FICI) | Observed indifference range |
|---|---|---|---|
| Carbapenem-resistant A. baumannii: colistin + meropenem | ~20 to 100 isolates | Approximately 30% to 70% | Commonly 25% to 60% |
| MDR P. aeruginosa: polymyxin + beta-lactam combinations | ~25 to 120 isolates | Approximately 20% to 60% | Commonly 30% to 70% |
| MRSA: vancomycin + selected beta-lactams | ~20 to 80 isolates | Approximately 15% to 55% | Commonly 35% to 75% |
Interpretation tip: if your calculated FICI is close to a cutoff (for example, 0.50 or 1.00), repeat testing with technical and biological replicates. Borderline values are most sensitive to dilution and reading variability.
How to Set Up Data for Reliable FICI Calculation
Correct mathematics is only part of the job. You also need quality experimental inputs. Inaccurate MIC endpoints create inaccurate FICI values, even if your formula is perfect. Build your workflow around consistency:
- Use standardized inoculum density and growth phase.
- Keep incubation time, atmosphere, and medium constant.
- Record both visible growth endpoint and any instrument-derived endpoint if your protocol requires both.
- Run controls: growth control, sterility control, and known reference strain.
- Document exact dilution step size used in the checkerboard.
Common Mistakes When Calculating FICI
- Mixing units: one MIC in mg/L and another in mcg/mL without conversion can distort results.
- Using non-corresponding endpoints: comparing MIC at one inhibition criterion for monotherapy and another criterion in combination.
- Not handling off-scale MICs: when MIC is above highest tested concentration, use clearly defined censoring rules in your methods.
- Over-interpreting a single run: replicate variation can move values across category thresholds.
- Ignoring mechanism: a favorable FICI does not guarantee clinical efficacy if pharmacokinetics, penetration, or toxicity are limiting.
FICI vs Time-Kill: Why Both Matter
Checkerboard FICI is efficient, scalable, and useful for screening many pairings quickly. Time-kill experiments provide kinetic context, showing bactericidal behavior over time and concentration. A strong workflow often uses checkerboard to prioritize combinations and time-kill to validate the most promising candidates. If results conflict, review concentration selection, exposure duration, and strain-specific behavior before drawing conclusions.
How to Report FICI in Manuscripts and Lab Reports
For technical clarity and reproducibility, include:
- MIC values alone and in combination for each drug.
- Calculated FIC for each agent and total FICI.
- Interpretation framework and threshold values used.
- Replicate count and agreement metrics.
- Method details: medium, inoculum, incubation, plate format, and reading method.
A concise reporting format helps downstream users compare your results to other datasets and prevents misclassification due to hidden methodological differences.
Clinical Relevance and Practical Decision-Making
FICI is an in vitro decision-support metric, not a standalone clinical directive. Treatment decisions should integrate patient factors, infection source, achievable tissue exposure, toxicity risk, local epidemiology, and susceptibility profile. Still, FICI can be very useful in high-resistance contexts, especially when monotherapy options are limited and combination design needs a rational starting point.
In antimicrobial stewardship and translational research, FICI can also support ranking of combination candidates for follow-up in dynamic models, animal systems, or pharmacodynamic simulations. Think of it as a structured screening tool that reduces guesswork.
Authority References and Further Reading
- NIH National Library of Medicine: Review articles discussing checkerboard and antimicrobial synergy testing approaches
- NIH NLM: Methodological discussion of antimicrobial combination testing and interpretation
- CDC (.gov): Antibiotic resistance context and surveillance resources
Bottom Line
To calculate fractional inhibitory concentration index correctly, you need accurate MIC measurements, precise FIC arithmetic, and transparent interpretation thresholds. The calculator on this page automates the math, but scientific quality still depends on your experimental design and reporting discipline. If you apply standardized methods and replicate testing, FICI becomes a powerful, reproducible tool for evaluating antimicrobial combinations.